Boston Scientific (BSX): Sen. Markwayne Mullin disclosed a purchase $1K–$15K
Sen. Markwayne Mullin disclosed a purchase of Boston Scientific in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 29 days
- Disclosure lag
- Traded
- Oct 3, 2023
- Disclosed
- Nov 1, 2023
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 8, 2023Congress · 1 personMembers of Congress: 2 sales
- Sep 13, 2023CongressDisclosed purchase of BSX — reported range $15,001 - $50,000
- Sep 27, 2023FDARecall: EXALT Model D Single-Use Duodenoscope: Outer box UPN# M00542420 & Outer box UPN# M0054242CE0.
- Sep 27, 2023FDARecall: EXALT Model D Single-Use Duodenoscope, 2 pack: Outer box UPN# M00542421, Inner box UPN # M00542420 & Outer box UPN# M0054242CE1, Inner box UPN # M0054242CE0.
- Oct 3, 2023 · this disclosureCongressDisclosed purchase of BSX — reported range $1,001 - $15,000
What came next
- Oct 27, 2023FDAFDA device clearance: AXIOS Stent and Electrocautery-Enhanced Delivery System (6mmx8mm); AXIOS Stent and Electrocautery-Enhanced Delivery System (8mmx8mm); AXIOS Stent and Electroca…
- Oct 27, 2023FDAFDA device clearance: Polaris X Unidirectional Steerable Diagnostic Catheter
- Nov 22, 2023FDAFDA device clearance: IceSeed 1.5 CX 90º Needle (H7493967433170); IceSeed 1.5 CX S 90º Needle (H7493967233100)
- Nov 28, 2023FDAFDA device clearance: Gold Probe Bipolar Electrohemostasis Catheter; Injection Gold Probe Bipolar Electrohemostasis Catheter
- Nov 30, 2023FDAFDA device clearance: 14F iSLEEVE Introducer Set
- Nov 30, 2023FDARecall: Boston Scientific Model 3120 ZOOM LATITUDE Programmer/Recorder/Monitor (PRM) installed with Model 2892 Programmer Application Software used for the following p…
- Dec 4, 2023CongressDisclosed sale of BSX — reported range $1,001 - $15,000
- Dec 11, 2023FDAFDA device clearance: FARADRIVE Steerable Sheath
- Dec 12, 2023FDAFDA device clearance: StoneSmart Connect Console, LithoVue Elite Standard Deflection, LithoVue Elite Reverse Deflection
- Dec 19, 2023FDARecall: EndoVive Replacement Button Kit w/ ENFIT 28F 2.8 CM, Outer Box UPN M00509500 or M00509510.
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 1 fund holdings report (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
Other recent filings by Sen. Markwayne Mullin
- Senate eFD periodic transaction report at UnitedHealth (UNH)Mar 10, 2026
- Senate eFD periodic transaction report at AutoZone (AZO)Mar 10, 2026
- Senate eFD periodic transaction report at Intuit (INTU)Mar 10, 2026
- Senate eFD periodic transaction report at Monolithic Power Systems (MPWR)Mar 2, 2026
- Senate eFD periodic transaction report at McKesson Corporation (MCK)Mar 2, 2026
The full history of Sen. Markwayne Mullin is on the profile page.
How this filing works
Explore the data
Other disclosures at Boston Scientific
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- House Clerk periodic transaction reportSep 25, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
